251 results
Page 7 of 13
8-K
EX-99.2
kku973nepyunil
29 Oct 20
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
7:06am
8-K
EX-99.1
ndqer90g c6052j
29 Oct 20
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
7:06am
8-K
EX-99.1
r8j9m697gjxs fnju3
9 Oct 20
FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder
5:20pm
S-8
EX-5.1
l005c4xm45mpdlaog
29 Jul 20
Registration of securities for employees
5:09pm
S-8 POS
EX-5.1
3cz6tl5yx7bg
29 Jul 20
Registration of securities for employees (post-effective amendment)
4:51pm
S-8 POS
EX-5.1
zclkpgpgu
29 Jul 20
Registration of securities for employees (post-effective amendment)
4:41pm
S-8 POS
EX-5.1
s6snb74f0xs5n m55
29 Jul 20
Registration of securities for employees (post-effective amendment)
4:35pm
S-8 POS
EX-5.1
qpd84xt4hvfoj
29 Jul 20
Registration of securities for employees (post-effective amendment)
4:30pm
S-8 POS
EX-5.1
awqesgoatnjqwxfs
29 Jul 20
Registration of securities for employees (post-effective amendment)
4:23pm
8-K
EX-99.2
442ny55
29 Jul 20
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
7:08am
8-K
EX-99.1
uifrgufc w3
29 Jul 20
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
7:08am
8-K
EX-99.2
oymjoqx
29 Apr 20
Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
7:05am
8-K
EX-99.1
qcf 2ec5b
29 Apr 20
Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
7:05am
8-K
EX-99.2
ug5odroa2i8bpnc1df
13 Feb 20
Results of Operations and Financial Condition
7:06am
8-K
EX-99.1
s14r4qa2c 9z10hw199
13 Feb 20
Results of Operations and Financial Condition
7:06am